OSCR

Oscar Health Inc

NYSE: OSCR · HEALTHCARE · HEALTHCARE PLANS

$22.00

+3.86% today

Updated 2026-06-05

Market cap

$8.52B

P/E ratio

—

P/S ratio

0.64x

EPS (TTM)

$-0.54

Dividend yield

—

52W range

$11 – $29

Volume

7.5M

Market cap

$8.52B

P/E ratio

—

P/S ratio

0.64x

EPS (TTM)

$-0.54

Dividend yield

—

52W range

$11 – $29

Volume

7.5M

Oscar Health Inc (OSCR) Financial Forecast & Price Target 2030

Research-backed projections from analyst consensus, management guidance, and sector analysis.

OSCR · Oscar Health Inc · Price target summary

Current

$22.00

Consensus

$18,220.00

+82718.18%

2030 Target

$47.62

+116.45%

DCF

—

Current price

$22.00

Analyst consensus

$18,220.00

+82718.18%

2030 Target

$47.62

+116.45%

Intrinsic (DCF)

—

12 analysts:

2 Buy8 Hold3 Sell

Management guidance

Oscar Health reaffirmed 2026 revenue guidance of $18.7B-$19.0B (midpoint $18.85B) and operational earnings of $250M-$450M at the Raymond James Conference in March 2026. CEO Mark Bertolini has positioned 2026 as the company's profitability inflection year, with expectations for margin recovery driven by ACA exchange stabilization and administrative efficiency gains.

Sources: Management guidance, analyst consensus, sector analysishigh confidence

OSCR · Oscar Health Inc · Revenue & price projection · 2023–2030E

Actual revenue Projected revenue Base case Bull to bear range

Bear case (2030)

$29.76

$27.0B Rev × 0.3x P/S

Base case (2030)

$47.62

$27.0B Rev × 0.5x P/S

Bull case (2030)

$77.38

$27.0B Rev × 0.8x P/S

WallStSmart.com

Financial forecast — research-backed

Metric	2025	2026 (E)	2027 (E)	2028 (E)	2029 (E)	2030 (E)
Revenue	$11.7B	$18.9B	$20.4B	$22.3B	$24.5B	$27.0B
Revenue growth	27.5%	61.0%	8.2%	9.3%	9.9%	10.2%
EPS	$-1.74	$0.69	$1.32	$1.75	$2.15	$2.65
P/S ratio	—	0.5x	0.5x	0.5x	0.5x	0.5x
Implied price	—	$33.73	$35.71	$39.68	$43.65	$47.62

OSCR · Oscar Health Inc · Catalysts & risks

Growth catalysts

+ ACA exchange market stabilization and repricing actions in 2026-2027

+ Margin expansion from administrative efficiency and improved claims management

+ Membership growth acceleration (reached 3.4M members by Q1 2026, +41% YoY)

+ Platform transition to infrastructure-like healthcare model with expanded services

+ Medicare Advantage expansion opportunity (CMS finalized 2027 MA payments +2.48%)

+ CEO insider buying ($11.92M purchase in April 2026 signals confidence)

Key risks

- Higher-than-expected medical claims costs in ACA market could compress margins

- Regulatory policy shifts affecting ACA subsidies and exchange dynamics

- Rising operational costs despite efficiency initiatives

- Increased competitive pressure from larger insurers (UnitedHealth, CVS, Cigna)

- Risk adjustment volatility and CMS payment policy changes

- Execution risk on platform expansion and new product launches

Methodology

Oscar Health Inc's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 12 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.

WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: May 8, 2026.